Together, these results demonstrate that loss of EC JAM-C leads to development of morphologically and functionally abnormal tumor blood vessels that could account for reduced tumor growth in the present ID8 model of ovarian cancer. This evidence concerns the gene JAM3 and ovarian carcinoma.